Real-World Cost-Effectiveness of Oxaliplatin in Stage III Colon Cancer: A Synthesis of Clinical Trial and Daily Practice Evidence

Research output: Contribution to journal › Article › Academic › peer-review

13 Citations (Scopus)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{ce57ace322b74d81858078942e9de03a,

title = "Real-World Cost-Effectiveness of Oxaliplatin in Stage III Colon Cancer: A Synthesis of Clinical Trial and Daily Practice Evidence",

author = "{van Gils}, Chantal and {de Groot}, Saskia and Ken Redekop and M Koopman and CJA Punt and {Uyl - de Groot}, Carin",

year = "2013",

month = may,

day = "9",

doi = "10.1007/s40273-013-0061-6",

language = "English",

volume = "31",

pages = "703--718",

journal = "PharmacoEconomics",

issn = "1170-7690",

publisher = "Adis",

number = "8",

}

TY - JOUR

T1 - Real-World Cost-Effectiveness of Oxaliplatin in Stage III Colon Cancer: A Synthesis of Clinical Trial and Daily Practice Evidence

AU - van Gils, Chantal

AU - de Groot, Saskia

AU - Redekop, Ken

AU - Koopman, M

AU - Punt, CJA

AU - Uyl - de Groot, Carin

PY - 2013/5/9

Y1 - 2013/5/9

U2 - 10.1007/s40273-013-0061-6

DO - 10.1007/s40273-013-0061-6

M3 - Article

VL - 31

SP - 703

EP - 718

JO - PharmacoEconomics

JF - PharmacoEconomics

SN - 1170-7690

IS - 8

ER -